Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma (Q33374692)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma |
scientific article |
Statements
1 reference
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma (English)
1 reference
Julie M Vose
1 reference
Ann LaCasce
1 reference
Donna Neuberg
1 reference
Margaret A Shipp
1 reference
Michael J Robertson
1 reference
Brad S Kahl
1 reference
Sven de Vos
1 reference
Mary Laughlin
1 reference
Patrick J Flynn
1 reference
Kendrith Rowland
1 reference
Jose C Cruz
1 reference
Stuart L Goldberg
1 reference
Luna Musib
1 reference
Christelle Darstein
1 reference
Nathan Enas
1 reference
Jeffery L Kutok
1 reference
Jon C Aster
1 reference
Kerry J Savage
1 reference
Donald Thornton
1 reference
Christopher A Slapak
1 reference
1 reference
Identifiers
1 reference